We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Influence of a Inhaled Corticosteroid Therapy Versus Corticosteroid + LABA Therapy on the FeNO of Asthmatic Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00515775
Recruitment Status : Completed
First Posted : August 14, 2007
Last Update Posted : February 13, 2009
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of the study is to investigate, whether the FeNO concentration of asthmatic children is influenced differently by inhaled corticosteroid compared to inhaled corticosteroid + long acting beta agonist. The study hypothesis is that the FeNO concentration is more decreased in patients with a combination therapy compared to those with a corticosteroid mono therapy.

Condition or disease
Allergic Asthma

Study Design

Study Type : Observational
Estimated Enrollment : 27 participants
Observational Model: Case-Crossover
Time Perspective: Prospective
Study Start Date : September 2005
Primary Completion Date : June 2008
Study Completion Date : October 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma
U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   6 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Allergic asthmatics
Criteria

Inclusion Criteria:

  • allergic asthma since > 6 months equal or lower corticosteroid therapy before study entry FEV1>50%

Exclusion Criteria:

  • severe asthma respiratory infection within the last 4 weeks smoking
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00515775


Locations
Germany
University Children´s Hospital, Technical University of Dresden
Dresden, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Investigators
Principal Investigator: Christian Vogelberg, MD University Children´s Hospital, Technical University of Dresden
More Information

Responsible Party: Dr. Christian Vogelberg, University Children's Hospital, Technical University Dresden
ClinicalTrials.gov Identifier: NCT00515775     History of Changes
Other Study ID Numbers: D5890L00015
First Posted: August 14, 2007    Key Record Dates
Last Update Posted: February 13, 2009
Last Verified: October 2008